Iovance Biotherapeutics (NASDAQ:IOVA) Downgraded by Truist Financial to Hold
Truist Financial cut shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, MarketBeat.com reports. A number of other equities research analysts also recently weighed in on the company. Chardan Capital lowered their price target on Iovance Biotherapeutics from […]
Truist Financial cut shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, MarketBeat.com reports. A number of other equities research analysts also recently weighed in on the company. Chardan Capital lowered their price target on Iovance Biotherapeutics from […]
